Live Webinar
Smart Drug Product Development: Rational formulation designs for highly concentrated biologics
Wednesday, 25 June 2025 · 4:00 p.m CEST

Register to join

About This Webinar

The development of highly concentrated liquid formulations (HCLFs) for subcutaneous delivery presents significant challenges in stability, manufacturability, and scalability. Traditional platform approaches often fall short, leading to costly late-stage failures. But how can we systematically improve success rates?

At Leukocare, we believe in creating clarity from complexity. In this session, we’ll explore how a data science driven approach—leveraging AI, data analytics, and predictive modeling—can de-risk formulation development and accelerate decision-making.

This session will provide strategic insights into how data-driven methodologies enhance formulation decisions, mitigate risks, and create flexible yet scalable solutions for biologic drug development.

Meet the Speaker

Cornelius Pompe joined Leukocare’s management team in 2021, first as Vice President Research & Development and subsequently as Chief Development Officer (CDO). Before joining, Cornelius Pompe held leadership roles at different biotech companies and pharma service companies, amongst others Amgen, Micromet, LFB and Coriolis. He brings over 20 years of experience in the biotechnology and life sciences sectors, with a focus on operational strategy, process innovation, and team development.

Key takeaways include:

- Fundamental challenges in developing highly concentrated biologics—why they matter at a strategic level
- Common pitfalls in HCLF formulation that lead to program disruption
- A robust formulation as a multivariate challenge and how it can successfully be addressed with the means of biostatistics
- How the application of data science and a rational excipient selection accelerates the program

Register to join

Hosted by: